Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 3
1948 12
1949 8
1950 2
1951 2
1952 1
1953 1
1955 4
1956 2
1957 4
1958 3
1959 5
1960 3
1961 15
1962 13
1963 29
1964 85
1965 87
1966 88
1967 132
1968 122
1969 139
1970 161
1971 184
1972 192
1973 207
1974 242
1975 244
1976 321
1977 383
1978 386
1979 381
1980 465
1981 413
1982 489
1983 495
1984 645
1985 675
1986 655
1987 625
1988 632
1989 799
1990 894
1991 830
1992 1041
1993 1050
1994 1289
1995 1320
1996 1502
1997 1549
1998 1698
1999 1816
2000 2177
2001 2184
2002 2339
2003 2652
2004 2823
2005 3221
2006 3455
2007 3608
2008 3977
2009 4233
2010 4907
2011 5334
2012 5771
2013 5913
2014 6310
2015 6797
2016 6927
2017 7161
2018 7583
2019 7878
2020 8008
2021 3422
Text availability
Article attribute
Article type
Publication date

Search Results

117,340 results
Results by year
Filters applied: . Clear all
Page 1
Drug Combinations in Breast Cancer Therapy.
Fisusi FA, Akala EO. Fisusi FA, et al. Pharm Nanotechnol. 2019;7(1):3-23. doi: 10.2174/2211738507666190122111224. Pharm Nanotechnol. 2019. PMID: 30666921 Free PMC article. Review.
Breast cancer therapy involves a multidisciplinary approach comprising surgery, radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of breast cancer requires maximum therapeutic efficacy, with minimal undesirable effe
Breast cancer therapy involves a multidisciplinary approach comprising surgery, radiotherapy, neoadjuvant and adjuvant
The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer.
Al-Hilli Z, Boughey JC. Al-Hilli Z, et al. Chin Clin Oncol. 2016 Jun;5(3):37. doi: 10.21037/cco.2016.03.26. Epub 2016 Apr 22. Chin Clin Oncol. 2016. PMID: 27164853 Free article. Review.
Neoadjuvant chemotherapy (NAC) has traditionally been used in locally advanced and inflammatory breast cancer, allowing for a reduction in disease volume and therefore optimizing surgical resection of disease in the breast. ...The aim of this review is …
Neoadjuvant chemotherapy (NAC) has traditionally been used in locally advanced and inflammatory breast cancer, allowing …
Support with nutrition for women receiving chemotherapy for breast cancer.
Gilmour F, Williams A. Gilmour F, et al. Br J Nurs. 2018 Feb 22;27(4):S4-S9. doi: 10.12968/bjon.2018.27.4.S4. Br J Nurs. 2018. PMID: 29457937 Review.
Nurses are in a unique position to provide nutritional advice and information to women with breast cancer who are undergoing chemotherapy, supporting them with making decisions regarding nutrition and diet. ...Weight gain was identified as a specific problem …
Nurses are in a unique position to provide nutritional advice and information to women with breast cancer who are undergoing …
Neoadjuvant chemotherapy in the treatment of breast cancer.
Redden MH, Fuhrman GM. Redden MH, et al. Surg Clin North Am. 2013 Apr;93(2):493-9. doi: 10.1016/j.suc.2013.01.006. Epub 2013 Feb 11. Surg Clin North Am. 2013. PMID: 23464698 Review.
Randomized prospective trials have demonstrated that patients with early-stage breast cancer preferring breast conservation can benefit from neoadjuvant chemotherapy, achieving about a 25% complete and greater than 80% partial pathologic response. Thes …
Randomized prospective trials have demonstrated that patients with early-stage breast cancer preferring breast conserva …
Progress in adjuvant systemic therapy for breast cancer.
Pondé NF, Zardavas D, Piccart M. Pondé NF, et al. Nat Rev Clin Oncol. 2019 Jan;16(1):27-44. doi: 10.1038/s41571-018-0089-9. Nat Rev Clin Oncol. 2019. PMID: 30206303 Review.
The prognosis of patients with early stage breast cancer has greatly improved in the past three decades. Following the first adjuvant endocrine therapy and chemotherapy trials, continuous improvements of clinical outcomes have been achieved through int …
The prognosis of patients with early stage breast cancer has greatly improved in the past three decades. Following the first a …
Current and future role of neoadjuvant therapy for breast cancer.
Untch M, Konecny GE, Paepke S, von Minckwitz G. Untch M, et al. Breast. 2014 Oct;23(5):526-37. doi: 10.1016/j.breast.2014.06.004. Epub 2014 Jul 14. Breast. 2014. PMID: 25034931 Free article. Review.
Neoadjuvant systemic chemotherapy is an option for breast cancer patients who would require adjuvant chemotherapy otherwise based on clinical and histological examination and imaging. ...It is not yet clear if neoadjuvant therapy might improve o …
Neoadjuvant systemic chemotherapy is an option for breast cancer patients who would require adjuvant chemotherapy
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet. 2015 Oct 3;386(10001):1353-1361. doi: 10.1016/S0140-6736(15)60908-4. Epub 2015 Jul 23. Lancet. 2015. PMID: 26211824 Free article.
We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer. METHODS: We sought individual patient data from all unconfounded trials in early breast cancer that randomised between bis …
We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer
[Systemic treatment of early breast cancer - current state of knowledge after the conference St Gallen 2017].
Sarosiek T. Sarosiek T. Pol Merkur Lekarski. 2017 Nov 23;43(257):232-236. Pol Merkur Lekarski. 2017. PMID: 29231918 Review. Polish.
Breast cancer is the most commonly diagnosed malignancy in women around the globe. ...The international biennial St Gallen conference, the world's most prominent breast cancer specialists, who are struggling to address major clinical problems in
Breast cancer is the most commonly diagnosed malignancy in women around the globe. ...The international biennial St Gallen con
Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.
Read RL, Flitcroft K, Snook KL, Boyle FM, Spillane AJ. Read RL, et al. ANZ J Surg. 2015 May;85(5):315-20. doi: 10.1111/ans.12975. Epub 2015 Jan 22. ANZ J Surg. 2015. PMID: 25612239 Review.
Neoadjuvant chemotherapy (NAC) is a legitimate alternative to first-line surgical therapy for the treatment of breast cancer patients, as level one evidence shows the effect on overall survival is equivalent to that of adjuvant chemotherapy. ... …
Neoadjuvant chemotherapy (NAC) is a legitimate alternative to first-line surgical therapy for the treatment of breast
117,340 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page